Antianaphylactic agents. 1. 2-(Acylamino)oxazoles

Area of Science:

• Medicinal Chemistry
• Immunology
• Pharmacology

Background:

• Anaphylaxis involves the release of mediators like slow-reacting substance of anaphylaxis (SRS-A).
• Developing inhibitors of SRS-A release is crucial for managing allergic reactions.

Purpose of the Study:

• To synthesize novel 2-(acylamino)oxazole derivatives.
• To evaluate the biological properties of these compounds, focusing on their ability to inhibit SRS-A release and protect against anaphylaxis.

Main Methods:

• Synthesis of 35 2-(acylamino)oxazole compounds.
• In vitro testing using sensitized guinea pig and human chopped lung to measure SRS-A release.
• In vivo testing in a modified Herxheimer test using guinea pigs to assess protection against anaphylaxis.

Main Results:

• The majority of synthesized 2-(acylamino)oxazoles demonstrated significant inhibition of SRS-A release from guinea pig lung tissue.
• Several compounds also effectively inhibited SRS-A release from human lung tissue.
• A subset of these compounds provided protection to guinea pigs challenged with anaphylaxis.

Conclusions:

• 2-(Acylamino)oxazoles represent a promising class of compounds for inhibiting SRS-A release.
• These findings suggest potential therapeutic applications for 2-(acylamino)oxazoles in treating anaphylaxis and related allergic conditions.